PubRank

Christopher G Morris

Author PubWeight™ 150.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 2003 3.93
2 Radiotherapy for pleomorphic adenoma. Am J Otolaryngol 2012 2.04
3 Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2007 1.97
4 Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007 1.62
5 External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 2002 1.60
6 Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 2004 1.59
7 Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol 2010 1.58
8 Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009 1.52
9 Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 2002 1.45
10 Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010 1.44
11 Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 2014 1.42
12 Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 2006 1.34
13 Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009 1.33
14 T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2010 1.32
15 Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004 1.30
16 Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 2006 1.27
17 Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 2005 1.26
18 External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol 2005 1.21
19 Skin carcinoma of the head and neck with perineural invasion. Am J Otolaryngol 2011 1.20
20 Mucosal melanoma of the head and neck. Am J Clin Oncol 2008 1.19
21 The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys 2006 1.18
22 Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 2005 1.17
23 Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol 2005 1.15
24 Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol 2013 1.13
25 Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck 2003 1.13
26 Ewing tumors of the head and neck. Am J Clin Oncol 2010 1.11
27 Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. Radiother Oncol 2010 1.11
28 Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 2007 1.11
29 Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope 2008 1.09
30 Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 2006 1.07
31 Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005 1.06
32 Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. Cancer 2004 1.06
33 Aggressive fibromatosis. Am J Clin Oncol 2005 1.06
34 Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 2009 1.05
35 Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003 1.05
36 Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer 2012 1.04
37 Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol 2012 1.04
38 Management of sinonasal undifferentiated carcinoma. Head Neck 2008 1.04
39 Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol 2013 1.04
40 Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope 2010 1.02
41 Carcinoma of the skin with perineural invasion. Head Neck 2003 1.02
42 Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance. J Am Coll Surg 2005 1.02
43 Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys 2009 1.01
44 Definitive radiotherapy in the management of paragangliomas arising in the head and neck: a 35-year experience. Head Neck 2008 1.01
45 Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol 2006 1.00
46 The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity. Cancer 2011 0.99
47 Favorable outcomes of pediatric patients treated with radiotherapy to the central nervous system who develop radiation-induced meningiomas. Int J Radiat Oncol Biol Phys 2010 0.98
48 Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol 2005 0.98
49 Voice rehabilitation after total laryngectomy and postoperative radiation therapy. J Clin Oncol 2002 0.97
50 A review of interventions to reduce health disparities in cardiovascular disease in African Americans. Ethn Dis 2009 0.96
51 Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys 2006 0.96
52 Adult head and neck soft tissue sarcomas. Am J Clin Oncol 2005 0.96
53 Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck. Am J Clin Oncol 2007 0.95
54 Late toxicity following craniospinal radiation for early-stage medulloblastoma. Acta Oncol 2014 0.95
55 A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer 2007 0.94
56 Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 2005 0.94
57 Impact of race on outcome after definitive radiotherapy for squamous cell carcinoma of the head and neck. Cancer 2003 0.94
58 Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer 2013 0.94
59 Radiotherapy for carcinoma in situ of the true vocal cords. Head Neck 2002 0.94
60 Postoperative adjuvant and salvage radiotherapy for prostate cancer: impact on freedom from biochemical relapse and survival. Urology 2004 0.94
61 A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol 2009 0.92
62 Solitary plasmacytoma. Am J Clin Oncol 2009 0.92
63 Long-term outcomes of radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 2008 0.92
64 Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck 2007 0.92
65 Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 2003 0.92
66 Radiation therapy for angiosarcoma: the 35-year University of Florida experience. Am J Clin Oncol 2013 0.92
67 Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons. Int J Radiat Oncol Biol Phys 2003 0.90
68 Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion. Cancer 2005 0.90
69 Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol 2015 0.89
70 Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? Cancer 2008 0.88
71 Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection. Int J Radiat Oncol Biol Phys 2007 0.88
72 Merkel cell carcinoma: treatment and outcomes. Cancer 2005 0.88
73 Neurotropic melanoma of the head and neck with clinical perineural invasion. Am J Clin Oncol 2005 0.88
74 Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer. Acta Oncol 2012 0.87
75 Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 2005 0.87
76 The dynamic tumor bed: volumetric changes in the lumpectomy cavity during breast-conserving therapy. Int J Radiat Oncol Biol Phys 2009 0.87
77 Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy. Am J Clin Oncol 2006 0.87
78 Severe dry eye syndrome after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 2011 0.86
79 Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer? Head Neck 2003 0.86
80 Hip fractures and pain following proton therapy for management of prostate cancer. Acta Oncol 2013 0.86
81 Radiotherapy for benign head and neck paragangliomas: a 45-year experience. Cancer 2014 0.86
82 Radiation therapy for mucosal melanoma of the head and neck. Am J Clin Oncol 2015 0.85
83 Effectiveness and morbidity associated with reirradiation in conservative salvage management of recurrent soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2008 0.85
84 Long-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida. Am J Clin Oncol 2013 0.85
85 Squamous cell carcinoma of the anal margin. J Surg Oncol 2004 0.85
86 Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation. Laryngoscope 2010 0.85
87 T3 and T4 true vocal cord squamous carcinomas treated with external beam irradiation: a single institution's 35-year experience. Am J Clin Oncol 2007 0.84
88 Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer. Surgery 2007 0.84
89 Multimodality local therapy for retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys 2012 0.84
90 Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity. Int J Radiat Oncol Biol Phys 2012 0.84
91 Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer 2010 0.84
92 Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2010 0.84
93 Impact of young age on prognosis for head and neck cancer: a matched-pair analysis. Head Neck 2005 0.84
94 Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003 0.83
95 Adjuvant radiotherapy in the management of soft tissue sarcoma involving the distal extremities. Am J Clin Oncol 2006 0.83
96 Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys 2012 0.83
97 Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy. Am J Clin Oncol 2009 0.83
98 Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor. Am J Clin Oncol 2016 0.83
99 Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck. Head Neck 2007 0.83
100 Carcinoma of the nasal cavity and paranasal sinuses. Laryngoscope 2009 0.83
101 Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. Int J Radiat Oncol Biol Phys 2011 0.83
102 Mohs resection and postoperative radiotherapy for head and neck cancers with incidental perineural invasion. Am J Otolaryngol 2013 0.82
103 Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines. Am J Vet Res 2008 0.82
104 Radiotherapy for basal cell carcinoma of the medial canthus region. Laryngoscope 2009 0.82
105 Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Acta Oncol 2013 0.82
106 Analysis of dose at the site of second tumor formation after radiotherapy to the central nervous system. Int J Radiat Oncol Biol Phys 2011 0.82
107 Intracranial ependymomas treated with radiotherapy: long-term results from a single institution. J Neurooncol 2010 0.82
108 Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus. Int J Radiat Oncol Biol Phys 2008 0.81
109 Angiosarcoma after breast-conserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART). Acta Oncol 2013 0.81
110 Radiotherapy for dermatofibrosarcoma protuberans. Am J Clin Oncol 2014 0.81
111 Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. Am J Clin Oncol 2007 0.81
112 Long-term outcome after radiotherapy for FIGO stage IIIB and IVA carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2007 0.81
113 Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression. Int J Radiat Oncol Biol Phys 2011 0.81
114 Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer. Cancer 2010 0.81
115 Larynx-sparing radiotherapy for squamous cell carcinoma from an unknown head and neck primary site. Am J Clin Oncol 2005 0.81
116 Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: the University of Florida experience. Int J Radiat Oncol Biol Phys 2008 0.81
117 Factors predictive of survival for esophageal carcinoma treated with preoperative radiotherapy with or without chemotherapy followed by surgery. J Surg Oncol 2003 0.81
118 Radiation therapy for management of t1-t2 glottic cancer at a private practice. Am J Clin Oncol 2010 0.80
119 Elective neck dissection for second primary after previous definitive radiotherapy. Am J Otolaryngol 2012 0.80
120 Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials. Acta Oncol 2013 0.80
121 Definitive radiotherapy for ewing tumors of extremities and pelvis: long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys 2008 0.80
122 Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery. Cancer 2005 0.79
123 Long-term clinical and functional outcomes after treatment for localized Ewing's tumor of the lower extremity. Int J Radiat Oncol Biol Phys 2007 0.79
124 Oligodendroglioma: does deferring treatment compromise outcome? Am J Clin Oncol 2003 0.79
125 Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring. Am J Clin Oncol 2009 0.79
126 Delayed breast cellulitis: an evolving complication of breast conservation. Int J Radiat Oncol Biol Phys 2006 0.79
127 Squamous cell carcinoma of the anal margin: the university of Florida experience. Am J Clin Oncol 2011 0.79
128 Definitive radiotherapy for nasopharyngeal carcinoma. Am J Clin Oncol 2006 0.79
129 Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades. Am J Clin Oncol 2015 0.79
130 Preoperative radiotherapy alone or combined with chemotherapy followed by transanal excision for rectal adenocarcinoma. Am J Clin Oncol 2006 0.79
131 Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. Int J Radiat Oncol Biol Phys 2011 0.78
132 Comparing size evaluation methods for acoustic neuroma after stereotactic radiosurgery. Radiat Med 2007 0.78
133 Radiation therapy for minor salivary gland carcinoma. Laryngoscope 2009 0.78
134 Transanal excision with radiation therapy for rectal adenocarcinoma. Clin Med Res 2012 0.78
135 Surgery and postoperative radiotherapy for squamous cell carcinoma of the larynx and pharynx. Am J Clin Oncol 2006 0.78
136 Definitive altered fractionation radiotherapy and concomitant weekly cisplatin for locally advanced head and neck cancer. Am J Clin Oncol 2009 0.78
137 Definitive radiotherapy for juvenile nasopharyngeal angiofibroma. Am J Clin Oncol 2006 0.78
138 Definitive radiotherapy for carcinoma in situ of the true vocal cords. Am J Clin Oncol 2010 0.78
139 Radiation treatment for Ewing family of tumors in adults: the University of Florida experience. Int J Radiat Oncol Biol Phys 2008 0.78
140 Esthesioneuroblastoma of the nasal cavity. Am J Clin Oncol 2015 0.78
141 Breast-conserving therapy in patients with bilateral breast cancer: do today's treatment choices burn bridges for tomorrow? Int J Radiat Oncol Biol Phys 2005 0.78
142 Definitive radiotherapy for head-and-neck cancer with radiographically positive retropharyngeal nodes: incomplete radiographic response does not necessarily indicate failure. Int J Radiat Oncol Biol Phys 2006 0.78
143 Radiotherapy with or without surgery for maxillary sinus squamous cell carcinoma: should the clinical N0 neck be treated? Am J Clin Oncol 2011 0.78
144 Celecoxib to decrease urinary retention associated with prostate brachytherapy. Brachytherapy 2003 0.78
145 Long-term results of radiotherapy for early-stage testicular seminoma. Am J Clin Oncol 2005 0.78
146 Definitive radiation therapy for squamous cell carcinoma of the soft palate. Head Neck 2008 0.78
147 Fractionated radiotherapy in the management of benign vascular tumors. Am J Clin Oncol 2012 0.77
148 Long-term Outcomes After Radiosurgery for Temporal Bone Paragangliomas. Am J Clin Oncol 2015 0.77
149 Optimal image-guidance scenario with cone-beam computed tomography in conventionally fractionated radiotherapy for lung tumors. Am J Clin Oncol 2010 0.77
150 Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor. Am J Clin Oncol 2016 0.77
151 Unresectable squamous cell carcinoma of the lung: an outcomes study. Int J Radiat Oncol Biol Phys 2009 0.77
152 Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: a prospective, randomized trial. Cancer 2005 0.77
153 Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease? Am J Clin Oncol 2014 0.77
154 Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. Acta Oncol 2013 0.77
155 Definitive radiotherapy alone or combined with a planned neck dissection for squamous cell carcinoma of the pharyngeal wall. Cancer 2003 0.77
156 Hypopituitarism after radiotherapy for extracranial head and neck cancers. Head Neck 2008 0.77
157 Late Effects After Radiotherapy for Childhood Low-grade Glioma. Am J Clin Oncol 2016 0.77
158 Spinal and paraspinal Ewing tumors. Int J Radiat Oncol Biol Phys 2009 0.77
159 Pushing the limits of radiotherapy for atypical and malignant meningioma. Am J Clin Oncol 2005 0.77
160 Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques? Am J Clin Oncol 2009 0.77
161 Cutaneous Merkel cell carcinoma. Am J Otolaryngol 2011 0.77
162 Radiotherapy for spermatic cord sarcoma. Am J Clin Oncol 2013 0.77
163 Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma. Laryngoscope 2014 0.76
164 Elective neck management for high-grade salivary gland carcinoma. Am J Otolaryngol 2013 0.76
165 Antemortem diagnosis of asbestosis by screening chest radiograph correlated with postmortem histologic features of asbestosis: a study of 273 cases. J Occup Med Toxicol 2009 0.76
166 Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification? Cancer 2004 0.76
167 Radiotherapy for squamous cell carcinoma of the nasal vestibule. Am J Clin Oncol 2007 0.75
168 Management of supraglottic carcinoma. Int J Radiat Oncol Biol Phys 2002 0.75
169 Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence. Am J Otolaryngol 2013 0.75
170 Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer? Am J Clin Oncol 2016 0.75
171 Prognostic significance of paraglottic space invasion in T2N0 glottic carcinoma. Am J Clin Oncol 2007 0.75
172 A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. Acta Oncol 2014 0.75
173 Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis. Am J Clin Oncol 2017 0.75
174 Hypopituitarism after radiotherapy for extracranial head and neck cancers in pediatric patients. Am J Clin Oncol 2008 0.75
175 Radiotherapy and radiosurgery for benign neurofibromas. Am J Clin Oncol 2005 0.75
176 Does surgical closure technique affect early mammographic detection of tumor recurrence after breast-conserving therapy? Am J Clin Oncol 2009 0.75
177 Surgery and postoperative radiotherapy for adenoid cystic carcinoma of the lung. Am J Clin Oncol 2006 0.75
178 Local control in non-metastatic medulloblastoma. Acta Oncol 2014 0.75
179 Radiation therapy for hemangioendothelioma: the university of Florida experience. Am J Clin Oncol 2014 0.75
180 Chest wall Ewing sarcoma family of tumors: long-term outcomes. Int J Radiat Oncol Biol Phys 2010 0.75
181 Role of radiotherapy for pleomorphic adenoma. Am J Clin Oncol 2005 0.75
182 Outcomes of Definitive Radiation Therapy for Primary Vaginal Carcinoma. Am J Clin Oncol 2015 0.75
183 Differences between current and historical breast cancer axillary lymph node irradiation based on arm position: implications for radiation oncologists. Am J Clin Oncol 2009 0.75
184 Long-term Outcomes Following Radiotherapy for Adolescent Patients With Nonmetastatic WHO Type III Nasopharyngeal Carcinoma. Am J Clin Oncol 2016 0.75
185 Postoperative radiotherapy for cervix cancer incidentally discovered after a simple hysterectomy for either benign conditions or noninvasive pathology. Am J Clin Oncol 2010 0.75
186 Radiotherapy alone or combined with chemotherapy for the treatment of squamous cell carcinoma of the base of the tongue. Am J Clin Oncol 2014 0.75
187 Low-dose prophylactic craniospinal radiotherapy for intracranial germinoma. Int J Radiat Oncol Biol Phys 2006 0.75
188 Improving Patient-reported Pain During Radiotherapy Through Nurse Involvement and Patient Education. Am J Clin Oncol 2017 0.75
189 Is the Berg axillary lymph node categorization useful in the 3D environment? Am J Clin Oncol 2007 0.75
190 Definitive radiotherapy for squamous cell carcinoma of the anal canal. Am J Clin Oncol 2010 0.75
191 Radiotherapy Alone or With Chemotherapy in the Management of Carcinoma of the Supraglottic Larynx: A 25-Year Community Hospital Experience. Am J Clin Oncol 2017 0.75
192 Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity: Utility and Application of the Toronto Extremity Salvage Score (TESS). Am J Clin Oncol 2016 0.75
193 Favorable Outcome of Hurthle Cell Carcinoma of the Thyroid Treated With Total Thyroidectomy, Radioiodine, and Selective Use of External-Beam Radiotherapy. Am J Clin Oncol 2017 0.75
194 Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation. Int J Radiat Oncol Biol Phys 2006 0.75
195 Neck Management with Total Laryngectomy and Adjuvant Radiotherapy in Locally Advanced Larynx Cancer. Oncol Res Treat 2017 0.75